Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2017, Article ID 7357150, 10 pages
https://doi.org/10.1155/2017/7357150
Research Article

Fabrication, Characterization, and In Vivo Evaluation of Famotidine Loaded Solid Lipid Nanoparticles for Boosting Oral Bioavailability

1Department of Pharmacy, University of Malakand, Chakdara, Dir (L), Khyber Pakhtunkhwa 18800, Pakistan
2Nano-Biotech Group, National Institute for Biotechnology and Genetic Engineering, Faisalabad 38000, Pakistan
3Ningbo Institute of Materials Technology and Engineering (NIMTE), Chinese Academy of Sciences (CAS), Ningbo, Zhejiang, China

Correspondence should be addressed to Mir Azam Khan; moc.oohay@687mazarim

Received 31 July 2017; Revised 14 November 2017; Accepted 20 November 2017; Published 14 December 2017

Academic Editor: Mohamed Bououdina

Copyright © 2017 Muhammad Shafique et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Kawabata, K. Wada, M. Nakatani, S. Yamada, and S. Onoue, “Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications,” International Journal of Pharmaceutics, vol. 420, no. 1, pp. 1–10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Das, W. K. Ng, P. Kanaujia, S. Kim, and R. B. H. Tan, “Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: Effects of process variables,” Colloids and Surfaces B: Biointerfaces, vol. 88, no. 1, pp. 483–489, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Harde, M. Das, and S. Jain, “Solid lipid nanoparticles: An oral bioavailability enhancer vehicle,” Expert Opinion on Drug Delivery, vol. 8, no. 11, pp. 1407–1424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. B. Sarmento, S. Martins, D. Ferreira, and E. B. Souto, “Oral insulin delivery by means of solid lipid nanoparticles,” International Journal of Nanomedicine, vol. 2, no. 4, pp. 743–749, 2007. View at Google Scholar · View at Scopus
  5. R. H. Müller, K. Mäder, and S. Gohla, “Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 50, no. 1, pp. 161–177, 2000. View at Publisher · View at Google Scholar · View at Scopus
  6. W. Mehnert and K. Mäder, “Solid lipid nanoparticles: production, characterization and applications,” Advanced Drug Delivery Reviews, vol. 47, no. 2-3, pp. 165–196, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Shah, D. Eldridge, E. Palombo, and I. Harding, “Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential,” Journal of Physical Science, vol. 25, no. 1, pp. 59–75, 2014. View at Google Scholar · View at Scopus
  8. H. A. Ebrahimi, Y. Javadzadeh, M. Hamidi, and M. B. Jalali, “Repaglinide-loaded solid lipid nanoparticles: effect of using different surfactants/stabilizers on physicochemical properties of nanoparticles,” DARU Journal of Pharmaceutical Sciences, vol. 23, no. 1, article 46, 2015. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Vitorino, F. A. Carvalho, A. J. Almeida, J. J. Sousa, and A. A. C. C. Pais, “The size of solid lipid nanoparticles: An interpretation from experimental design,” Colloids and Surfaces B: Biointerfaces, vol. 84, no. 1, pp. 117–130, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Kinoshita, T. Hashimoto, A. Kawamura et al., “Effects of famotidine, mosapride and tandospirone for treatment of functional dyspepsia,” Alimentary Pharmacology and Therapeutics, Supplement, vol. 21, no. s2, pp. 37–41, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. D. P. Patel, R. R. Shah, A. P. Patel, and P. K. Tank, “Development and validation of first order derivative uv-spectroscopic method for estimation of ibuprofen and famotidine in synthetic mixture,” Pharma science Monitor, vol. 3, no. 4, 2012. View at Google Scholar
  12. R. M. O. Aman, M. M. O. Meshali, and G. M. A. Abdelghani, “Ion-exchange complex of famotidine: sustained release and taste masking approach of stable liquid dosage form,” Drug Discoveries & Therapeutics, vol. 8, no. 6, pp. 268–275, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. F. M. Mady, A. E. Abou-Taleb, K. A. Khaled et al., “Evaluation of carboxymethyl-β-cyclodextrin with acid function: Improvement of chemical stability, oral bioavailability and bitter taste of famotidine,” International Journal of Pharmaceutics, vol. 397, no. 1-2, pp. 1–8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. F. M. Mady, A. E. Abou-Taleb, K. A. Khaled et al., “Enhancement of the aqueous solubility and masking the bitter taste of famotidine using drug/SBE-β-CyD/Povidone K30 complexation approach,” Journal of Pharmaceutical Sciences, vol. 99, no. 10, pp. 4285–4294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. J. Patel and J. K. Patel, “Design and evaluation of famotidine mucoadhesive nanoparticles for aspirin induced ulcer treatment,” Brazilian Archives of Biology and Technology, vol. 56, no. 2, pp. 223–236, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Avdeef, C. M. Berger, and C. Brownell, “pH-metric solubility. 2: correlation between the acid-base titration and the saturation shake-flask solubility-pH methods,” Pharmaceutical Research, vol. 17, no. 1, pp. 85–89, 2000. View at Publisher · View at Google Scholar · View at Scopus
  17. K. C. Yeh, A. N. Chremos, J. H. Lin et al., “Single‐dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies,” Biopharmaceutics & Drug Disposition, vol. 8, no. 6, pp. 549–560, 1987. View at Publisher · View at Google Scholar · View at Scopus
  18. T. Takabatake, H. Ohta, M. Maekawa et al., “Pharmacokinetics of famotidine, a new H2-receptor antagonist, in relation to renal function,” European Journal of Clinical Pharmacology, vol. 28, no. 3, pp. 327–331, 1985. View at Publisher · View at Google Scholar · View at Scopus
  19. S. A. Wissing, O. Kayser, and R. H. Müller, “Solid lipid nanoparticles for parenteral drug delivery,” Advanced Drug Delivery Reviews, vol. 56, no. 9, pp. 1257–1272, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Abbaspour, B. S. Makhmalzadeh, Z. Arastoo, A. Jahangiri, and R. Shiralipour, “Effect of anionic polymers on drug loading and release from clindamycin phosphate solid lipid nanoparticles,” Tropical Journal of Pharmaceutical Research, vol. 12, no. 4, pp. 477–482, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K.-H. Song, S.-J. Chung, and C.-K. Shim, “Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts,” Journal of Controlled Release, vol. 106, no. 3, pp. 298–308, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Venkatesan, K. Uchino, K. Amagase, Y. Ito, N. Shibata, and K. Takada, “Gastro-intestinal patch system for the delivery of erythropoietin,” Journal of Controlled Release, vol. 111, no. 1-2, pp. 19–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Rehman, A. Madni, A. Ihsan et al., “Solid and liquid lipid-based binary solid lipid nanoparticles of diacerein: In vitro evaluation of sustained release, simultaneous loading of gold nanoparticles, and potential thermoresponsive behavior,” International Journal of Nanomedicine, vol. 10, pp. 2805–2814, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. B. Ozturk, S. Argin, M. Ozilgen, and D. J. McClements, “Formation and stabilization of nanoemulsion-based vitamin e delivery systems using natural surfactants: Quillaja saponin and lecithin,” Journal of Food Engineering, vol. 142, pp. 57–63, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Abdelwahed, G. Degobert, S. Stainmesse, and H. Fessi, “Freeze-drying of nanoparticles: formulation, process and storage considerations,” Advanced Drug Delivery Reviews, vol. 58, no. 15, pp. 1688–1713, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. B. Tiţa, A. Fuliaş, G. Bandur, E. Marian, and D. Tiţa, “Compatibility study between ketoprofen and pharmaceutical excipients used in solid dosage forms,” Journal of Pharmaceutical and Biomedical Analysis, vol. 56, no. 2, pp. 221–227, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Uprit, R. K. Sahu, A. Roy, and A. Pare, “Preparation and characterization of minoxidil loaded nanostructured lipid carrier gel for effective treatment of alopecia,” Saudi Pharmaceutical Journal, vol. 21, pp. 379–385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Dubes, H. Parrot-Lopez, W. Abdelwahed et al., “Scanning electron microscopy and atomic force microscopy imaging of solid lipid nanoparticles derived from amphiphilic cyclodextrins,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 55, no. 3, pp. 279–282, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Racault, F. Langlais, and R. Naslain, “Solid-state synthesis and characterization of the ternary phase Ti3SiC2,” Journal of Materials Science, vol. 29, no. 13, pp. 3384–3392, 1994. View at Publisher · View at Google Scholar · View at Scopus
  30. D. Hou, C. Xie, K. Huang, and C. Zhu, “The production and characteristics of solid lipid nanoparticles (SLNs),” Biomaterials, vol. 24, no. 10, pp. 1781–1785, 2003. View at Publisher · View at Google Scholar · View at Scopus
  31. A. del Pozo-Rodríguez, M. A. Solinís, A. R. Gascón, and J. L. Pedraz, “Short- and long-term stability study of lyophilized solid lipid nanoparticles for gene therapy,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 71, no. 2, pp. 181–189, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. U. Bhardwaj and D. J. Burgess, “A novel USP apparatus 4 based release testing method for dispersed systems,” International Journal of Pharmaceutics, vol. 388, no. 1-2, pp. 287–294, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. A. C. Moffat, M. D. Osselton, B. Widdop, and L. Y. Galichet, “Clarke's analysis of drugs and poisons,” 2004.
  34. Roohullah, Z. Iqbal, F. Nasir et al., “Sustained release carbamezapine matrix tablets prepared by solvent-evaporation technique using different polymers,” Middle East Journal of Scientific Research, vol. 15, no. 10, pp. 1368–1374, 2013. View at Publisher · View at Google Scholar · View at Scopus
  35. F. Barboza, D. D. Vecchia, M. P. Tagliari, M. A. S. Silva, and H. K. Stulzer, “Differential scanning calorimetry as a screening technique in compatibility studies of acyclovir extended release formulations,” Pharmaceutical Chemistry Journal, vol. 43, no. 6, pp. 363–368, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. P. Costa and J. M. Sousa Lobo, “Modeling and comparison of dissolution profiles,” European Journal of Pharmaceutical Sciences, vol. 13, no. 2, pp. 123–133, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. A. A. Sadiq and A. Abdul Rassol, “Formulation and evaluation of silibinin loaded solid lipid nanoparticles for peroral use targeting lower part of gastrointestinal tract,” Int J Pharm PharmSci, vol. 6, no. 1, pp. 55–67, 2014. View at Google Scholar
  38. M. Barzegar-Jalali, “Kinetic analysis of drug release from nanoparticles,” Journal of Pharmacy Pharmaceutical Sciences, vol. 11, no. 1, pp. 167–177, 2008. View at Publisher · View at Google Scholar
  39. A. Kovacevic, S. Savic, G. Vuleta, R. H. Müller, and C. M. Keck, “Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure,” International Journal of Pharmaceutics, vol. 406, no. 1-2, pp. 163–172, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Baharifar, G. Tavoosidana, R. Karimi et al., “Optimization of self-assembled chitosan/streptokinase nanoparticles and evaluation of their cytotoxicity and thrombolytic activity,” Journal of Nanoscience and Nanotechnology, vol. 15, no. 12, pp. 10127–10133, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. P. P. Kumar, P. Gayatri, R. Sunil, S. Jagamohan, and Y. M. Rao, “Atorvastatin loaded solidlipid nanoparticles: formulation, optimization, and in vitro characterization,” IOSR Journal of Pharmacy, vol. 2, no. 5, pp. 23–32, 2012. View at Publisher · View at Google Scholar
  42. J. Liu, W. Hu, H. Chen, Q. Ni, H. Xu, and X. Yang, “Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery,” International Journal of Pharmaceutics, vol. 328, no. 2, pp. 191–195, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. H. S. M. Ali, P. York, A. M. A. Ali, and N. Blagden, “Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling,” Journal of Controlled Release, vol. 149, no. 2, pp. 175–181, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. Y. Liu, J. Pan, and S.-S. Feng, “Nanoparticles of lipid monolayer shell and biodegradable polymer core for controlled release of paclitaxel: Effects of surfactants on particles size, characteristics and in vitro performance,” International Journal of Pharmaceutics, vol. 395, no. 1-2, pp. 243–250, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. S. Khan, M. D. Matas, J. Zhang, and J. Anwar, “Nanocrystal preparation: low-energy precipitation method revisited,” Crystal Growth and Design, vol. 13, no. 7, pp. 2766–2777, 2013. View at Publisher · View at Google Scholar · View at Scopus
  46. E. S. Farboud, S. A. Nasrollahi, and Z. Tabbakhi, “Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies,” International Journal of Nanomedicine, vol. 6, pp. 611–617, 2011. View at Google Scholar · View at Scopus
  47. J. Y. Fang, C. L. Fang, C. H. Liu, and Y. H. Su, “Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC),” European Journal of Pharmaceutics and Biopharmaceutics, vol. 70, no. 2, pp. 633–640, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. A. Khawam and D. R. Flanagan, “Basics and applications of solid-state kinetics: a pharmaceutical perspective,” Journal of Pharmaceutical Sciences, vol. 95, no. 3, pp. 472–498, 2006. View at Publisher · View at Google Scholar
  49. B. C. Hancock and G. Zografi, “Characteristics and significance of the amorphous state in pharmaceutical systems,” Journal of Pharmaceutical Sciences, vol. 86, no. 1, pp. 1–12, 1997. View at Google Scholar
  50. S. C. Yang, L. F. Lu, Y. Cai, J. B. Zhu, B. W. Liang, and C. Z. Yang, “Body distribution in mice of intravenously injected camptothecin solid lipid nanoparticles and targeting effect on brain,” Journal of Controlled Release, vol. 59, no. 3, pp. 299–307, 1999. View at Publisher · View at Google Scholar · View at Scopus